Intellectual Property Rights and Biodiversity Conservation: An Interdisciplinary Analysis of the Values of Medicinal PlantsTimothy M. Swanson Cambridge University Press, 1995 - 271 pages The urgent need to ensure the conservation of biological diversity is now widely recognized, but practical measures to protect endangered species and habitats are still small-scale and generally limited to developed countries. This volume offers a detailed analysis of the economic and scientific rationales for biodiversity conservation. It discusses the justification for, and implementation of intellectual property rights regimes as incentive systems to encourage conservation. The contributions form an interdisciplinary approach encompassing fields of study such as evolutionary biology, chemistry, economics and legal studies. The arguments are presented through the case study of medicinal plant use in the pharmaceutical industry. The book will be of interest and relevance to a broad spectrum of conservationists from research students to policy makers. |
Contents
Diversity and sustainability evolution information and institutions | 1 |
Plant communities and the generation of information | 17 |
Chemical diversity in plants | 19 |
Ethnobotany and the search for balance between use and conservation | 45 |
The value of plantgenerated information in pharmaceuticals | 65 |
The pharmaceutical discovery process | 67 |
The role of plant screening and plant supply in biodiversity conservation drug development and health care | 93 |
The economic value of plantbased pharmaceuticals | 127 |
The institutions for regulating information from diversity | 139 |
The appropriation of evolutions values an institutional analysis of intellectual property regimes and biodiversity conservation | 141 |
Preserving biodiversity the role of property rights | 176 |
The importance of cultural diversity in biodiversity conservation | 199 |
Medicinal plants indigenous medicine and conservation of biodiversity in Ghana | 201 |
Biodiversity and the conservation of medicinal plants issues from the perspective of the developing world | 232 |
| 254 | |
Other editions - View all
Intellectual Property Rights and Biodiversity Conservation: An ... Timothy M. Swanson No preview available - 1995 |
Common terms and phrases
alkaloids amino acids application approach areas assets Balick bark benefits biodiversity biodiversity conservation biological diversity biotechnology Biotics cancer cell CH3 H chemical clinical collection conversion cost Costa cultural derived developing countries discovery disease drug development ecological economic value effective enzyme ethnobotanical evolution evolutionary example existing flavonoids forest forms gene genetic material genetic resources Ghana global H CH3 habitat harvesting herbal human societies important INBio incentives industrialised countries inhibitors initial institutions intellectual property rights investments knowledge land medicinal plants Merck & Co metabolism microorganisms molecules National natural products niche organisms overexploitation patent pharmaceutical industry plant communities plant medicines plant screening plant species plant-based drugs portfolio potential practitioners primary problem protection range recognised result role royalties screening program secondary compounds secondary metabolites Secondary Plant specialised strategy structure sustainable synthetic taxol terpenoids trade traditional medicine tropical value of biological
References to this book
Kinship, Law and the Unexpected: Relatives are Always a Surprise Marilyn Strathern No preview available - 2005 |
Beyond Aesthetics: Art and the Technologies of Enchantment Christopher Pinney,Nicholas Thomas No preview available - 2001 |